Monitoring and treatment of intracranial hypertension
Nathan M. Bass – 13 February 2012
Safety of anidulafungin in solid organ transplant recipients
J.M. Aguado, E. Varo, P. Usetti, J.C. Pozo, A. Moreno, M. Catalán, O. Len, M. Blanes, A. Solé, P. Muñoz, M. Montejo, the TOSCANA Study Group – 12 February 2012 – The aim of this study was the evaluation of the safety of anidulafungin in adult solid organ transplantation (SOT) recipients. During the study period (14 months), we included all consecutive SOT recipients from 14 centers who received anidulafungin for at least 48 hours for the treatment of invasive fungal infections (IFIs) or as prophylaxis. Relevant clinical and analytical information on clinical charts was reviewed.
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
Norah A. Terrault, Michelle E. Roland, Thomas Schiano, Lorna Dove, Michael T. Wong, Fred Poordad, Margaret V. Ragni, Burc Barin, David Simon, Kim M. Olthoff, Lynt Johnson, Valentina Stosor, Dushyantha Jayaweera, John Fung, Kenneth E. Sherman, Aruna Subramanian, J. Michael Millis, Douglas Slakey, Carl L. Berg, Laurie Carlson, Linda Ferrell, Donald M. Stablein, Jonah Odim, Lawrence Fox, Peter G.
Hepatocellular carcinoma and model for end‐stage liver disease exceptions: The more we understand, the more challenging the allocation gets
Patrick G. Northup, Carl L. Berg – 10 February 2012
Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression
Maddalena Frau, Maria L. Tomasi, Maria M. Simile, Maria I. Demartis, Fabiana Salis, Gavinella Latte, Diego F. Calvisi, Maria A. Seddaiu, Lucia Daino, Claudio F. Feo, Stefania Brozzetti, Giuliana Solinas, Satoshi Yamashita, Toshikazu Ushijima, Francesco Feo, Rosa M. Pascale – 9 February 2012 – Down‐regulation of the liver‐specific MAT1A gene, encoding S‐adenosylmethionine (SAM) synthesizing isozymes MATI/III, and up‐regulation of widely expressed MAT2A, encoding MATII isozyme, known as MAT1A:MAT2A switch, occurs in hepatocellular carcinoma (HCC).
Balloon‐occluded retrograde transvenous obliteration for the treatment of gastric varices
Alia S. Dadabhai, Jonathan M. Fenkel, Daniel B. Brown, Loren Laine – 9 February 2012
Early diagnosis of hepatocellular carcinoma: It's not a matter of opinion
Eugenio Caturelli, Giorgia Ghittoni – 9 February 2012
Balloon‐occluded retrograde transvenous obliteration for the treatment of gastric varices
Alia S. Dadabhai, Jonathan M. Fenkel, Daniel B. Brown, Loren Laine – 9 February 2012
Peroxisome proliferator‐activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen‐induced liver toxicity
Andrew D. Patterson, Yatrik M. Shah, Tsutomu Matsubara, Kristopher W. Krausz, Frank J. Gonzalez – 9 February 2012 – Acetaminophen (APAP) overdose causes acute liver failure in humans and rodents due in part to the destruction of mitochondria as a result of increased oxidative stress followed by hepatocellular necrosis.
Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis
Wen‐Lung Ma, Cheng‐Lung Hsu, Chun‐Chieh Yeh, Ming‐Heng Wu, Chiung‐Kuei Huang, Long‐Bin Jeng, Yao‐Ching Hung, Tze‐Yi Lin, Shuyuan Yeh, Chawnshang Chang – 9 February 2012 – Early reports suggested androgen/androgen receptor (AR) signals promote hepatocarcinogenesis. However, all antiandrogen clinical trials failed in advanced hepatocellular carcinoma (HCC) without reasonable explanations. We examined AR functions in HCC cancer metastasis in this study.